Type I Sialidosis, A Normosomatic Lysosomal Disease, In The Differential Diagnosis Of Late-Onset Ataxia And Myoclonus: An Overview

Lysosomal storage diseases (LSDs) are rare to extremely rare monogenic disorders. Their incidence, however, has probably been underestimated owing to their complex clinical manifestations. Sialidosis is a prototypical LSD inherited as an autosomal recessive trait and caused by mutations in the NEU1 gene that result in a deficiency of alpha-N-acetyl neuraminidase 1 (NEU1). Two basic forms of this disease, type I and type II, are known. The dysmorphic type II form features LSD symptoms including congenital hydrops, dysmorphogenetic traits, hepatosplenomegaly and severe intellectual disability. The diagnosis is more challenging in the normosomatic type I forms, whose clinical findings at onset include ocular defects, ataxia and generalized myoclonus.Here we report the clinical, biochemical and molecular analysis of five patients with sialidosis type I. Two patients presented novel NEU1 mutations. One of these patients was compound heterozygous for two novel NEW missense mutations: c.530A > T (p.Asp177Val) and c.1010A > G (p.His337Arg), whereas a second patient was compound heterozygous for a known mutation and a novel c.839G > A (p.Arg280Gln) mutation. We discuss the impact of these new mutations on the structural properties of NEU1.We also review available clinical reports of patients with sialidosis type I, with the aim of identifying the most frequent initial clinical manifestations and achieving more focused diagnoses.